ITPR2 and cancer: The aberrant IP3R2 upregulation in some B-cell cancer cells may be an additional component in their addiction to high levels of Bcl-2 to suppress toxic Ca2+ signals in response to chronic BCR signaling, adding another level of heterogeneity of these cancer cells toward dysregulation of apoptosis-signaling cascades.